Novo A/S »

Brookfield Corp Cl A Ltd Vt Sh shares owned by Novo A/S

Quarter-by-quarter ownership of Brookfield Corp Cl A Ltd Vt Sh (BN) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Brookfield Corp Cl A Ltd Vt Sh

Tip: Access up to 7 years of quarterly data

All positions including Brookfield Corp Cl A Ltd Vt Sh held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brookfield Corp Cl A Ltd Vt Sh by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-09-30 $186M 3.5M 53.15
2024-06-30 $161M 3.9M 41.54
2024-03-31 $163M 3.9M 41.87
2023-12-31 $156M 3.9M 40.12
2023-09-30 $121M 3.9M 31.27

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Tempus Ai Cl A (TEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Vaxcyte (PCVX)
Mirum Pharmaceuticals (MIRM)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Insmed Com Par $.01 (INSM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
Arrivent Biopharma (AVBP)

View all positions for Novo A/S

Top funds holding Brookfield Corp Cl A Ltd Vt Sh

Partners Value Investments
Royal Bank of Canada
Principal Financial Group
Vanguard Group
Capital World Investors
Brookfield Asset Management
Pershing Square Capital Management
TD Asset Management
Goodman & Company, Investment Counsel
Jarislowsky, Fraser
Akre Capital Management
First Manhattan
Mackenzie Financial
Bank of Nova Scotia
CIBC Global Asset Management

View all funds holding Brookfield Corp Cl A Ltd Vt Sh